Diagnostics Industry
Filter News
Found 3,329 articles
-
numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics
1/21/2021
Leading metabolomics based diagnostics company numares AG and analytical instrumentation and solution provider Bruker Corporation have signed an agreement to collaborate to bring new diagnostics tests utilizing NMR to the laboratory market for unmet medical needs.
-
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
1/21/2021
LumiraDx, the next-generation point-of-care diagnostic testing company, announced multinational approvals of its SARS-CoV-2 Antigen Test.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
-
Blink Science, Inc. Names Eric Doherty President
1/19/2021
Healthcare Industry Veteran to Lead Blink Science Efforts in Developing the World's First Instant COVID POC Diagnostic Testing Device and Launching a Comprehensive Electronic Medical Passport
-
HTG Announces Board of Directors TransitionTimothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director
1/19/2021
HTG Molecular Diagnostics, Inc., a life science company whose mission is to advance precision medicine, announced that Timothy B. Johnson has resigned his positions as Executive Chairman and a member of HTG’s Board of Directors.
-
Cue's Molecular, Point-of-Care COVID-19 Tests Now Available in 10 States Under Health and Human Services and Department of Defense Pilot Program
1/19/2021
Cue Health Inc. announced that its molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rhode Island and Utah, as part of the joint $481 million program with the U.S. Department of Health and Human Services and the Department of Defense.
-
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19
1/14/2021
The first survey results reveal physicians seek new diagnostic tools and insights to improve COVID-19 management and patient outcomes
-
SKUP Reports Positive Evaluation of the LumiraDx SARS-CoV-2 Antigen Test in Symptomatic and Asymptomatic Patients
1/13/2021
LumiraDx, the next generation point-of-care diagnostic company, announced that the Scandinavian evaluation of laboratory equipment for point of care testing had published a positive evaluation of the LumiraDx SARS-CoV-2 Antigen Test.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
-
Biocept Issues Letter to Stockholders - Jan 12, 2021
1/12/2021
Biocept, Inc., a leading commercial provider of molecular testing to provide physicians with clinically actionable information to improve patient outcomes, announces that President and CEO Michael W. Nall has issued the following letter to stockholders:
-
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
1/12/2021
Novel liquid biopsy technology combines machine learning and low-cost cell free DNA genome-wide fragmentation profiles
-
Gravity Diagnostics Receives $20 Million Line of Credit from PNC Bank to Support COVID-19 Testing
1/12/2021
Gravity Diagnostics has announced that PNC Bank has authorized a $20 million line of credit to the diagnostics laboratory to support investments in inventory, equipment, and operations to increase its capacity and capabilities.
-
Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
1/12/2021
Accelerate Diagnostics, Inc. announced preliminary financial results for the fourth quarter and full year ending December 31, 2020.
-
Forest City Diagnostic Imaging Acquires Summit Radiology in Rockford, Illinois!
1/12/2021
Forest City Diagnostic Imaging, LLC announced that it has acquired Summit Radiology, LLC, in order to better serve the greater communities of Northern Illinois and Southern Wisconsin.
-
New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard®
1/12/2021
Cologuard's high specificity would help minimize risk and cost from unnecessary diagnostic procedures in this age group
-
Quotient Limited Wins 2021 BIG Innovation Award
1/12/2021
Quotient Limited, a commercial-stage diagnostics company, announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.
-
On Friday, the U.S. Food and Drug Administration (FDA) issued an official alert stating that it could trigger false negatives in COVID-19 tests.
-
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
1/11/2021
Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M
-
Biotricity Announces New Solution for Personal Heart Management with Bioheart
1/11/2021
Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format
-
Antech pioneers first automated rapid urine culture for cats and dogs
1/11/2021
Antech Diagnostics introduced the first automated test for rapid, reliable urine culture results for cats and dogs.